Beida Pharmaceutical: Shareholders holding more than 5% of the shares plan to reduce their holdings by no more than 3%.

Beijing University Medicine announced that its shareholder Beijing University Medical, holding 10.7247% of the shares, plans to reduce its holdings by no more than 17,879,622 shares, accounting for 3% of the total share capital, from February 11 to May 10, 2026, through centralized bidding and block trading due to its own capital needs. Among them, the reduction through centralized bidding will not exceed 1% for any consecutive 90 natural days, and the reduction through block trading will not exceed 2%. The implementation of this reduction plan may have uncertainties, but it will not lead to a change in the company's controlling interest, nor will it affect the company's governance and operation.